Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
Authors:
- Pershia SamadiPSPershia Samadi
- Abdallah Hadj TaharATAbdallah Hadj Tahar
- Nancy BélangerNBNancy Bélanger
- Thérèse Di PaoloTPThérèse Di Paolo
- 1 April 2010
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 34 (3) , 446-454
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Akt/GSK3 Signaling in the Action of Psychotropic DrugsAnnual Review of Pharmacology and Toxicology, 2009
- The Akt–GSK-3 signaling cascade in the actions of dopamineTrends in Pharmacological Sciences, 2007
- Dopamine depletion and subsequent treatment with l‐DOPA, but not the long‐lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatumJournal of Neurochemistry, 2007
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Relevance of the MPTP primate model in the study of dyskinesia priming mechanismsParkinsonism & Related Disorders, 2004
- Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascadeProceedings of the National Academy of Sciences, 2004
- Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeysMovement Disorders, 2003
- Presymptomatic compensation in Parkinson's disease is not dopamine-mediatedTrends in Neurosciences, 2003
- Dopamine Induces a PI3-Kinase-Independent Activation of Akt in Striatal Neurons: A New Route to cAMP Response Element-Binding Protein PhosphorylationJournal of Neuroscience, 2002
- Regulation and localization of tyrosine216phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degenerationProceedings of the National Academy of Sciences, 2000